Medpace (NASDAQ:MEDP – Get Free Report) and Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) are both healthcare companies, but which is the better stock? Get Medpace alerts:ProfitabilityThis table compares Medpace and Pacific Biosciences of California’s net margins, return on equity and return on assets. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53 billion 6.65 $451.12 million $17.06 35.31 Pacific Biosciences of California $160.01 million 2.24 -$546.38 million ($0.43) -2.69Medpace has higher revenue and earnings than Pacific Biosciences of California. Given Pacific Biosciences of California’s higher probable upside, analysts plainly believe Pacific Biosciences of California is more favorable than Medpace. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.